October 16, 2023
Dupree Lab awarded £1 million grant. Cambridge launches Founders led by Gerard Grech.
AstronauTx raises $61 million Series A.
April 24, 2023
Caristo Therapeutics secures $16.3 million Series A. Maxion Therapeutics awarded £2 million Innovate UK grant.
Convatec acquires 30Technology’s antimicrobial platform for £45 million.
April 17, 2023
The Good Food Institute raises £12 million. Solasta Bio raises £4 million funding.
SynaptixBio secures £13.2 million seed round.
April 10, 2023
Biotech VC fund H Tree Capital launches. Pastoral.ai has raised £205,000 pre-seed funding.
Syncona-backed Mosaic Therapeutics raises £22.5 million Series A.
April 3, 2023
BioCorteX secures $5 million seed funding. SR One raises £489 million biotech fund
M:M Bio-backed ThirtyFiveBio emerges raising $20 million seed funding.
March 20, 2023
Owlstone Medical and Bicycle Therapeutics enter collaboration. Eventum Orthopaedics secures £2.5 million funding.
Aldena Therapeutics raises $30 million investment.
March 13, 2023
Mendelian secures £1.4 million from the NHS Artificial Intelligence Lab. Adaptimmune acquires US TCR Therapeutics.
Opto Biosystems launches with £1.85 million pre-seed funding.
March 6, 2023
Spex Capital has launched a new £88 million healthtech fund. Vector Bioscience has been awarded £2.2 million non-dilutive funding.
Antiverse has raised £2.5 million funding.
February 26, 2023
Causeway has raised £8.75 million investment. SugaROx has secured £850,000 seed funding.
British Destiny Pharma has entered a £472 million collaboration with US Sebela Pharmaceuticals.
February 20, 2023
Panakes Partners has raised 175€ million Purple Fund. Cerevance has secured further $51 million Series B.
Maxion Therapeutics has raised $16 million Series A.
February 13, 2023
Prokarium has raised $30 million funding. Dxcover has raised £9.7 million Series A.
Evonetix has raised $24 million investment.
January 30, 2023
Multus has raised $9.5 million Series A. BlueYard Capital has backed Creasallis.
Grey Wolf Therapeutics has raised $49 million Series B.
January 16, 2023
PneumoWave has raised £7.5 million Series A. AstraZeneca acquires CinCor Pharma for $1.8 billion.
Oxford Cancer Analytics has raised $3.7 million follow-on funding.
January 9, 2023
Perspectum has raised $36 million Series C. TurbineAI and Cancer Research Horizons enter partnership.
Akamis Bio has raised $30 million funding.
December 26, 2022
Revive Eco has raised £375,000 investment. Adaptimmune has announced Biologics License Application for its TCR T-cell Therapy.
RQ Biotechnology has entered clinical trials.
December 19, 2022
STORM Therapeutics has secured $30 million Series B. Basecamp Research has raised £16.14 million Series A
Qkine has raised $4.3 million funding.
December 12, 2022
Jellagen has raised £8.76 million Series A. Owlstone Medical has launched Breath Biopsy VOC Atlas.
Pulmocide has raised $52 million extended Series C.
December 5, 2022
Accession Therapeutics raises £16 million Series A. Deep Science Ventures and AbbVie enter partnership.
V7 Labs raises $33 million Series A.
November 14, 2022
NRG Therapeutics has raised £16 million Series A. Kalium Health has raised over-subscribed investment round.
Osler Diagnostics has raised $85 million Series C.
November 4, 2022
Roslin Technologies raises £11 million Series A. ThermoFisher acquires The Binding Site Group for £2.25 billion.
Eagle Genomics raises $20 million.
October 28, 2022
VacV BioTherapeutics emerges from stealth with $3 million. AbbVie acquires DSJ Antibodies for $255 million.
Empyrean Neurosciences launches with £22 million Series A.
October 7, 2022
Acurable raises $11 million Series A. BenevolentAI and AstraZeneca expand collaboration.
Bloomsbury Genetic Therapies emerges from stealth.
September 30, 2022
Optellum raises $14m Series A. The Innovators Club announces Cohort III of SynBio startups.
Pheon Therapeutics emerges from stealth raising $68m Series A.
September 22, 2022
Roquefort Therapeutics acquires Oncogeni for £5.5 million. EQT Growth has raised €2.2 billion fund.
Booby Biome raises £1.3 million pre-seed funding.
September 9, 2022
Nodus Oncology has emerged from stealth. Phoremost has entered collaboration agreement with Roche.
Ducentis BioTherapeutics has been acquired for $400 million.
September 2, 2022
Claret Capital Partners has raised €297 million fund. Forcefield Therapeutics has published pivotal research.
Laverock Therapeutics has emerged from stealth.
August 26, 2022
Sevenless Therapeutics has secured €1.3 million funding. Liz McKee Anderson joins GSK Board of Directors.
Innovate UK budget boosted to £1 billion.
August 19, 2022
MiAlgae has raised £2.3 million. PsiOxus Therapeutics has appointed Howard Davis as CEO.
Constructive Bio has emerged from stealth raising $15 million.
August 12, 2022
AstraZeneca and Daiiko achieve FDA clearance for Enhertu. Arecor secures pivotal intellectual property.
Albumedix is acquired for £415 million.
August 5, 2022
Vicebio has emerged from stealth raising $18 million. Eleven Therapeutic has raised $22 million seed funding.
Gilead has acquired MiroBio for $405 million.
July 22, 2022
British Patient Capital appoints Catherine Lewis La Torre as CEO. RxCelerate launches RxNfinity platform.
Oxford Science Enterprise raises £250 million fund.
July 15, 2022
Tropic Biosciences obtains pivotal regulatory clearance. Bicycle Therapeutics and Genentech to expand collaboration.
The Crick secures £1b funding.
July 8, 2022
NATO launches Innovation Venture Fund. AstraZeneca to acquire TeneoTwo for $1.3 billion.
Tropic Biosciences raises $35 million.
July 1, 2022
F-star Therapeutics to be acquired for $161m. Cancer Research launches £15m Seed Fund.
MiroBio raises $97m Series B.
June 24, 2022
Epoch Biodesign emerges from stealth. UK Research & Innovation announces £481 million for the UK’s world-class R&D infrastructure.
Relation Therapeutics raises $25 million seed funding.
June 10, 2022
CHARM Therapeutics has raised $50 million series A. Deep Branch has been granted £4.8 million funding.
Transition Bio has raised $50 million series A.
June 3, 2022
Regeneron acquires worldwide exclusive rights for Sanofi’s Libtayo. Cathay raises €500 million life sciences fund.
moa Technology raises £35 million series B.
May 27, 2022
Duke Street Bio emerges from stealth. Katrine Bosley joins Advent Life Sciences.
Synthesis Capital has raised £238 million foodtech fund.
May 20, 2022
Sofinnova and Apollo Global Management form strategic partnership. RQ Bio enters partnership with AstraZeneca.
Elasmogen has raised £8 million round.
May 13, 2022
Ian Tomlinson & Tom Weaver join Maxion Therapeutics Board. Prof. Eric Miska, new Head of Biochemistry at Cambridge.
Amphista Therapeutics $2.3b partnership with BMS & Merck.
May 3, 2022
Parkwalk and Cambridge launch their 9th Fund . AviadoBio gets orphan designation for lead candidate.
OMass Therapeutics raises $100 million series B.
April 26, 2022
Cambridge Innovation Capital raises $300 million fund. Syncona-backed Forcefield Therapeutics emerges from stealth mode.
Record VC investment for British biotechs.
April 11, 2022
Better Origin has raised $16 million. Evonetix has secured pivotal IP.
Carlyle to acquire Abingworth.
March 29, 2022
Oxford Nanopore Technologies first full year post-IPO results are in. Sangamo to start first-in-class CAR-Treg therapy.
Record funding for UK university spin-outs in 2021
March 22, 2022
Hoxton Ventures raised $215 million fund. Oppilotech entered partnership with Evariste Technologies.
Olster Diagnostics is seeking to raise $100 million series C.
March 15, 2022
Coatue Ventures is coming to London. Blackstone and Sanofi close $330 million deal.
IQ Capital backs Boltzbit’s Generative AI.
March 8, 2022
UK startups raised the most seed funds across EU in Feb’22. John McCafferty, Life Sciences Inspiration of the Year Award.
Epsilogen raised $42m series B. Microbiotica raised $67m series B
March 1, 2022
EyeBio closes $65 million Series A with SV Health Investors. Complement Tx emerges from stealth mode.
Janssen & Legend Biotech BCMA CAR-T therapy gets FDA clearance.
February 22, 2022
Centauri Therapeutics closes $24 million Series A. Healx and Ovid Therapeutics enter strategic partnership.
Moderna to open mRNA R&D facility in the UK.
Copyright © 2022 Cambridge Biocapital. All rights reserved. Terms & Conditions.
